206 related articles for article (PubMed ID: 23065187)
1. Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.
Nakajima T; Kamijo Y; Yuzhe H; Kimura T; Tanaka N; Sugiyama E; Nakamura K; Kyogashima M; Hara A; Aoyama T
Glycoconj J; 2013 Aug; 30(6):553-60. PubMed ID: 23065187
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice.
Kimura T; Nakajima T; Kamijo Y; Tanaka N; Wang L; Hara A; Sugiyama E; Tanaka E; Gonzalez FJ; Aoyama T
PPAR Res; 2012; 2012():174932. PubMed ID: 22645601
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
[TBL] [Abstract][Full Text] [Related]
4. Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.
Luo Y; Xie C; Brocker CN; Fan J; Wu X; Feng L; Wang Q; Zhao J; Lu D; Tandon M; Cam M; Krausz KW; Liu W; Gonzalez FJ
Gastroenterology; 2019 Sep; 157(3):744-759.e4. PubMed ID: 31154022
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene.
Tian Y; Yang Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Lu Y; Moriya K; Koike K; Gonzalez FJ; Aoyama T
Glycoconj J; 2016 Dec; 33(6):927-936. PubMed ID: 27318478
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse.
Valasek MA; Clarke SL; Repa JJ
J Lipid Res; 2007 Dec; 48(12):2725-35. PubMed ID: 17726195
[TBL] [Abstract][Full Text] [Related]
8. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Sulfatides Physiological Function and Peroxisome Proliferator-Activated Receptor α.
Li TT; Li G; Hu R; Ji X; Liu C; Shao YT
Neurochem Res; 2023 Jul; 48(7):2059-2065. PubMed ID: 36879104
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARα by Fatty Acid Accumulation Enhances Fatty Acid Degradation and Sulfatide Synthesis.
Yang Y; Feng Y; Zhang X; Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Aoyama T
Tohoku J Exp Med; 2016 Oct; 240(2):113-22. PubMed ID: 27644403
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of hepatic VLDLR via PPARα is required for the triglyceride-lowering effect of fenofibrate.
Gao Y; Shen W; Lu B; Zhang Q; Hu Y; Chen Y
J Lipid Res; 2014 Aug; 55(8):1622-33. PubMed ID: 24899625
[TBL] [Abstract][Full Text] [Related]
13. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
[TBL] [Abstract][Full Text] [Related]
14. Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model.
Savas Ü; Machemer DEW; Hsu MH; Gaynor P; Lasker JM; Tukey RH; Johnson EF
J Biol Chem; 2009 Jun; 284(24):16541-16552. PubMed ID: 19366684
[TBL] [Abstract][Full Text] [Related]
15. PPAR
Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypertension and antihypertensive treatments on sulfatide levels in serum and its metabolism.
Guo R; Hu X; Yamada Y; Harada M; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
Hypertens Res; 2019 May; 42(5):598-609. PubMed ID: 30531843
[TBL] [Abstract][Full Text] [Related]
17. PPARα Induces the Expression of CAR That Works as a Negative Regulator of PPARα Functions in Mouse Livers.
Shizu R; Otsuka Y; Ishii C; Ezaki K; Yoshinari K
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835365
[TBL] [Abstract][Full Text] [Related]
18. Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice.
Ernst MC; Sinal CJ; Pollak PT
Pharmacol Res; 2010 Nov; 62(5):408-15. PubMed ID: 20654716
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate induces PPARα and BMP2 expression to stimulate osteoblast differentiation.
Kim YH; Jang WG; Oh SH; Kim JW; Lee MN; Song JH; Yang JW; Zang Y; Koh JT
Biochem Biophys Res Commun; 2019 Dec; 520(2):459-465. PubMed ID: 31607484
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB.
Bougarne N; Paumelle R; Caron S; Hennuyer N; Mansouri R; Gervois P; Staels B; Haegeman G; De Bosscher K
Proc Natl Acad Sci U S A; 2009 May; 106(18):7397-402. PubMed ID: 19376972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
